Revision Year: 2018
Erelan 400mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Red, oval-shaped, biconvex film coated tablets embossed “MC” with dimensions of nucleus 17.6mmx8mm. |
Each film-coated tablet contains 400mg moxifloxacin (as hydrochloride).
Excipient(s) with known effect: lactose monohydrate. Each film-coated tablet contains 68 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Moxifloxacin |
Moxifloxacin, a fourth-generation fluoroquinolone, has in vitro activity against a wide range of Gram-positive and Gram-negative pathogens. The bactericidal action of moxifloxacin results from the inhibition of both type II topoisomerases (DNA gyrase and topoisomerase IV) required for bacterial DNA replication, transcription and repair. |
| List of Excipients |
|---|
|
Tablet core: Microcrystalline cellulose (E460) Film-coat: Hypromellose (E464) |
Tablets are packed in Al/Al blisters.
Pack sizes of 5, 7, 10, 50, 70, 80 and 100 tablets.
Not all pack sizes may be marketed.
| Drug | Countries | |
|---|---|---|
| ERELAN | Cyprus, Spain, Malta, Romania |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
